CA1123738A - Pharmaceutical composition for rectal administration of cephalosporin - Google Patents

Pharmaceutical composition for rectal administration of cephalosporin

Info

Publication number
CA1123738A
CA1123738A CA332,022A CA332022A CA1123738A CA 1123738 A CA1123738 A CA 1123738A CA 332022 A CA332022 A CA 332022A CA 1123738 A CA1123738 A CA 1123738A
Authority
CA
Canada
Prior art keywords
pharmaceutical composition
rectal administration
salt
oil
administration according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA332,022A
Other languages
English (en)
French (fr)
Inventor
Hiroshi Kichijima
Junko Kidani
Mariko Tanimoto
Isamu Saikawa
Harumitsu Hiroshima
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toyama Chemical Co Ltd
Original Assignee
Toyama Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyama Chemical Co Ltd filed Critical Toyama Chemical Co Ltd
Application granted granted Critical
Publication of CA1123738A publication Critical patent/CA1123738A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/02Suppositories; Bougies; Bases therefor; Ovules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicinal Preparation (AREA)
CA332,022A 1978-07-25 1979-07-18 Pharmaceutical composition for rectal administration of cephalosporin Expired CA1123738A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP9000178A JPS5517342A (en) 1978-07-25 1978-07-25 Cephalosporin composition for rectal administaration
JP90001/78 1978-07-25

Publications (1)

Publication Number Publication Date
CA1123738A true CA1123738A (en) 1982-05-18

Family

ID=13986352

Family Applications (1)

Application Number Title Priority Date Filing Date
CA332,022A Expired CA1123738A (en) 1978-07-25 1979-07-18 Pharmaceutical composition for rectal administration of cephalosporin

Country Status (27)

Country Link
JP (1) JPS5517342A (de)
AU (1) AU529031B2 (de)
BE (1) BE877831A (de)
CA (1) CA1123738A (de)
CH (1) CH641351A5 (de)
CS (1) CS268651B2 (de)
DE (1) DE2929840A1 (de)
DK (1) DK159136C (de)
EG (1) EG15790A (de)
ES (1) ES482818A1 (de)
FI (1) FI792303A (de)
FR (1) FR2433945A1 (de)
GB (1) GB2028655B (de)
GR (1) GR69652B (de)
HU (1) HU180965B (de)
IE (1) IE48602B1 (de)
IL (1) IL57846A (de)
IN (1) IN151264B (de)
IT (1) IT1118900B (de)
LU (1) LU81546A1 (de)
NL (1) NL7905708A (de)
NO (1) NO792443L (de)
NZ (1) NZ191053A (de)
PH (1) PH16496A (de)
PT (1) PT69969A (de)
SE (1) SE7906340L (de)
ZA (1) ZA793734B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4760059A (en) * 1985-08-05 1988-07-26 Hoffmann-La Roche Inc. Rectal dosage form
AT392906B (de) * 1987-10-08 1991-07-10 Hoffmann La Roche Pharmazeutische praeparate zur oralen verabreichung
US5190748A (en) * 1988-11-22 1993-03-02 Hoffmann-La Roche Inc. Absorption enhancement of antibiotics
KR100739830B1 (ko) * 2001-03-23 2007-07-13 주식회사 하원제약 세파로스포린 유도체의 제조방법
US8075910B2 (en) 2004-05-20 2011-12-13 Pbm Pharmaceuticals, Inc. Oral compositions comprising edible oils and vitamins and/or minerals and methods for making oral compositions
CN113637026A (zh) * 2020-05-11 2021-11-12 承德医学院 一种头孢哌酮镁化合物、其制备方法及应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4950119A (de) * 1972-09-21 1974-05-15
JPS5538925B2 (de) * 1973-11-08 1980-10-07
GB1508071A (en) * 1976-01-19 1978-04-19 Toyama Chemical Co Ltd Cephalosporins and process for producing the same
JPS5244222A (en) * 1975-09-30 1977-04-07 Yamanouchi Pharmaceut Co Ltd Method of making insulin preparations for rectal application
JPS5822006B2 (ja) * 1975-12-12 1983-05-06 萬有製薬株式会社 チヨクチヨウトウヨヨウセフアトリジンセイザイノ セイゾウホウ
JPS6055486B2 (ja) * 1976-02-28 1985-12-05 富山化学工業株式会社 β−ラクタム環を有する化合物の直腸投与用組成物
JPS52156918A (en) * 1976-06-21 1977-12-27 Sumitomo Chem Co Ltd Preparation of penicillin pharmaceuticals for rectal infusion
JPS5619847A (en) * 1979-07-25 1981-02-24 Hitachi Ltd Manufacturing process for discharge lamp

Also Published As

Publication number Publication date
DK310079A (da) 1980-01-26
DK159136C (da) 1991-03-11
AU529031B2 (en) 1983-05-26
HU180965B (en) 1983-05-30
ZA793734B (en) 1980-07-30
GR69652B (de) 1982-07-07
IE791411L (en) 1980-01-25
CS268651B2 (en) 1990-04-11
FR2433945A1 (fr) 1980-03-21
NL7905708A (nl) 1980-01-29
BE877831A (fr) 1980-01-23
IN151264B (de) 1983-03-19
IT1118900B (it) 1986-03-03
GB2028655A (en) 1980-03-12
GB2028655B (en) 1982-12-22
FI792303A (fi) 1980-01-26
PT69969A (en) 1979-08-01
DE2929840A1 (de) 1980-02-14
CS516179A2 (en) 1989-09-12
EG15790A (en) 1986-09-30
DK159136B (da) 1990-09-10
CH641351A5 (de) 1984-02-29
NZ191053A (en) 1982-02-23
AU4919179A (en) 1980-01-31
LU81546A1 (fr) 1980-01-24
IL57846A (en) 1983-09-30
NO792443L (no) 1980-01-28
JPS5517342A (en) 1980-02-06
IL57846A0 (en) 1979-11-30
DE2929840C2 (de) 1989-01-12
IE48602B1 (en) 1985-03-20
IT7949844A0 (it) 1979-07-24
FR2433945B1 (de) 1984-12-14
SE7906340L (sv) 1980-01-27
PH16496A (en) 1983-10-28
ES482818A1 (es) 1980-09-01

Similar Documents

Publication Publication Date Title
US4525339A (en) Enteric coated oral dosage form
US5034415A (en) Treatment of diabetes mellitus
DE3017829C2 (de)
JP2002527465A (ja) ペンテチン酸塩を含有するプロポフォール組成物
CA1123738A (en) Pharmaceutical composition for rectal administration of cephalosporin
US4923862A (en) Topical preparation containing ofloxacin
JP2001524519A (ja) 哺乳動物の皮相組織における抗炎症剤としてのnmifa類
US11458077B2 (en) Two-phase cosmetic composition comprising a 4-(3-alkoxy-4-hydroxyphenyl)alkyl ketone
NZ231447A (en) Two component absorption enhancing system for antibacterial composition
CN101804051B (zh) 一种阿莫西林钠克拉维酸钾药物组合物脂质体注射剂
CN1149102C (zh) β-内酰胺抗生素的稳定化制剂
EP0302481A2 (de) Verwendung von freien Fettsäuren zur Herstellung eines Arzneimittels zur Behandlung von Diabetes mellitus
CA1334934C (en) Antibacterial composition for oral administration
US5260067A (en) Cytotropic heterogeneous molecular lipids (CHML) and process for preparing the same
KR820002224B1 (ko) 세파로스포린의 직장 투여용 의약 조성물의 제조 방법
JPS6055486B2 (ja) β−ラクタム環を有する化合物の直腸投与用組成物
US2541285A (en) Aqueous solutions of vitamin a esters
JP3044577B2 (ja) 高度不飽和脂肪酸含有光合成細菌の製造法
JPS5953423A (ja) セフアロスポリン化合物含有直腸投与用製剤組成物
JP2936226B2 (ja) 抗酸化剤
JPH0455167B2 (de)
JPS6230713A (ja) 経口用抗菌固型組成物
JPH0463047B2 (de)
JPH0543456A (ja) 血小板活性化因子産生阻害剤
JPH0225890B2 (de)

Legal Events

Date Code Title Description
MKEX Expiry